Aurora Cannabis Inc.
corporate_fare Company Profile
Aurora Cannabis Inc. (NASDAQ:ACB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for ACB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ACB spans SC14D9F/A, 6-K, SC14D9F.
Recent high-impact activity:
- Alberta Regulator Dismisses Curaleaf Challenge to Aurora's ATM Program
- Alberta Regulator Dismisses Curaleaf's Bid to Halt Aurora's ATM Program
- Regulator Dismisses Curaleaf's Bid to Halt Aurora's ATM Program
- Aurora Board Rejects Curaleaf's US$5.00 Hostile Bid; Discloses Bargain-Purchase Accounting and US$24M Officer Payouts
- Aurora Rejects Curaleaf's Revised Hostile Bid, Reveals Active Strategic Alternatives Process
Financial Snapshot
Short Interest & Short Volume
5.92 days to coverFINRA reported short interest of 8,196,688 shares in ACB as of the October 15, 2026 settlement, a 7.2% increase from the prior period — about 5.9 days to cover at its recent average daily volume. On October 30, 2026, 62.0% of ACB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
ACB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.